Evidence map›Paper›PMID 25387260›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2015

Weekly versus monthly testosterone administration on fast and slow skeletal muscle fibers in older adult males.

Robert H Fitts, James R Peters, E Lichar Dillon, William J Durham, Melinda Sheffield-Moore, Randall J Urban

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 25 citations in OpenAlex.

  1. Sexual dimorphisms in skeletal muscle: current concepts and research horizons.Journal of applied physiology (Bethesda, Md. : 1985) · 2024
    Review
  2. Beneficial Effects ofSports (Basel, Switzerland) · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Sarcopenia: Aging-Related Loss of Muscle Mass and Function.Physiological reviews · 2019 · on this map
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Robert H FittsDepartment of Biological Sciences (R.H.F., J.R.P.), Marquette University, Milwaukee, Wisconsin 53233; and Department of Internal Medicine (E.L.D., W.J.D., M.S.-M., R.J.U.), University of Texas Medical Branch at Galveston, Texas 77555.
James R Peters
E Lichar Dillon
William J Durham
Melinda Sheffield-Moore
Randall J Urban
The University of Texas Medical Branch at Galveston · USMarquette University · US

Funding

UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
Nutrition and Anabolic Interventions in Cancer CachexiaR01CA127971 · NCI · UNIVERSITY OF TEXAS MED BR GALVESTON · PI SHEFFIELD-MOORE, MELINDA · 2008 to 2014
$1.8M
Cyclic Testosterone on muscle function in older menR01AG022023 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI URBAN, RANDALL J · 2004 to 2009
$1.6M
NCATS NIH HHS UL1TR0000071NCATS NIH HHS UL1 TR000071NCI NIH HHS CA127971NCI NIH HHS R01 CA127971NIA NIH HHS AG022023NIA NIH HHS R01 AG022023
6 · The paper itself

Abstract

contextIn older adults, loss of mobility due to sarcopenia is exacerbated in men with low serum T. T replacement therapy is known to increase muscle mass and strength, but the effect of weekly (WK) vs monthly (MO) administration on specific fiber types is unknown.

objectiveTo determine the efficacy of WK vs MO T replacement on the size and functional capacity of individual fast and slow skeletal muscle fiber types. DESIGN, SETTING, AND PATIENTS: Subjects were randomized into a 5-month, double-blind, placebo-controlled trial. All subjects (ages, 61-71 y) were community-dwelling men who had T levels < 500 ng/dL.

interventionSubjects were dosed weekly for 5 months, receiving continuous T (WK, n = 5; 100 mg T enanthate, im injection), monthly cycled T (MO, n = 7; alternating months of T and placebo), or placebo (n = 7). Muscle biopsies of the vastus lateralis were obtained before and after treatment.

main outcome measuresMain outcomes for individual slow and fast fibers included fiber diameter, peak force (P0), rate of tension development, maximal shortening velocity, peak power, and Ca(2+) sensitivity.

resultsBoth treatments increased fiber diameter and peak power, with WK treatment 5-fold more effective than MO in increasing type I fiber P0. WK effects on fiber diameter and force were 1.5-fold higher in slow fibers compared to fast fibers. In fast type II fibers, diameter and P0 increased similarly between treatments. The increased power was entirely due to increased fiber size and force.

conclusionsIn conclusion, T replacement effects were fiber-type dependent, restricted to increases in cell size, P0, and peak power, and dependent on the paradigm selected (WK vs MO).

Indexed as

AgedDouble-Blind MethodDrug Administration ScheduleHormone Replacement TherapyHumansMaleMiddle AgedMuscle ContractionMuscle Fibers, Fast-TwitchMuscle Fibers, Slow-TwitchSarcopeniaTestosteroneTreatment OutcomeTestosterone

Identifiers

PMID25387260
PMCPMC4318887
OpenAlexW2020471695

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.